Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose

References

• SpergelJMPallerASAtopic dermatitis and the atopic marchJ Allergy Clin Immunol20031126 SupplS118S12714657842
   PubMed Web of Science ®Google Scholar
• SoterNAMorphology of atopic eczemaAllergy198944Suppl 916192683838
   PubMedGoogle Scholar
• BieberTAtopic dermatitisAnn Dermatol201022212513720548901
   PubMed Web of Science ®Google Scholar
• AbboudDHansonJChemokine neutralization as an innovative therapeutic strategy for atopic dermatitisDrug Discov Today201722470271127956056
   PubMed Web of Science ®Google Scholar
• LeungDYBieberTAtopic dermatitisLancet2003361935215116012531593
   PubMed Web of Science ®Google Scholar
• HenggeURRuzickaTSchwartzRACorkMJAdverse effects of topical glucocorticosteroidsJ Am Acad Dermatol2006541115 quiz 16–1816384751
   PubMed Web of Science ®Google Scholar
• RuzickaTAssmannTHomeyBTacrolimus: the drug for the turn of the millennium?Arch Dermatol1999135557458010328199
   PubMedGoogle Scholar
• RallisEKorfitisCGregoriouSRigopoulosDAssigning new roles to topical tacrolimusExpert Opin Investig Drugs200716812671276
   PubMed Web of Science ®Google Scholar
• SaekiHNakaharaTTanakaACommittee for Clinical Practice Guidelines for the Management of Atopic Dermatitis of Japanese Dermatological AssociationClinical practice guidelines for the management of atopic dermatitis 2016J Dermatol201643101117114527076388
   PubMed Web of Science ®Google Scholar
• SaekiHManagement of atopic dermatitis in JapanJ Nippon Med Sch201784121128331140
   PubMed Web of Science ®Google Scholar
• El–BatawyMMBosseilaMAMashalyHMHafezVSTopical calcineurin inhibitors in atopic dermatitis: a systematic review and meta–analysisJ Dermatol Sci2009542768719303745
   PubMed Web of Science ®Google Scholar
• SvenssonAChambersCGånemoAMitchellSAA systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitisCurr Med Res Opin20112771395140621563877
   PubMed Web of Science ®Google Scholar
• NoguchiATominagaMTakahashiNDifference in therapeutic effects of topically applied corticosteroid and tacrolimus on atopic dermatitis-like symptoms in NC/Nga miceJ Dermatol Sci2017861546228069324
   PubMed Web of Science ®Google Scholar
• DanbySGChittockJBrownKAlbenaliLHCorkMJThe effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitisBr J Dermatol2014170491492124328907
   PubMed Web of Science ®Google Scholar
• GuptaAKAdamiakAChowMTacrolimus: a review of its use for the management of dermatosesJ Eur Acad Dermatol Venereol200216210011412046809
   PubMed Web of Science ®Google Scholar
• de PaulisAStellatoCCirilloRCiccarelliAOrienteAMaroneGAnti-inflammatory effect of FK–506 on human skin mast cellsJ Invest Dermatol19929967237281281861
   PubMed Web of Science ®Google Scholar
• ZabawskiEJCostnerMCohenJBCockerellCJTacrolimus: pharmacology and therapeutic uses in dermatologyInt J Dermatol2000391072172711095187
   PubMed Web of Science ®Google Scholar
• RuzickaTBieberTSchöpfEA short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study GroupN Engl J Med1997337128168219295241
   PubMed Web of Science ®Google Scholar
• SoterNAFleischerABJrWebsterGFMonroeELawrenceITacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, safetyJ Am Acad Dermatol2001441 SupplS39S4611145794
   PubMed Web of Science ®Google Scholar
• YamanakaMYokotaSIwaoYNoguchiSItaiSDevelopment and evaluation of tacrolimus cream formulation using a binary solvent systemInt J Pharm20144641–2192624456671
   PubMedGoogle Scholar
• PanWQinMZhangGCombination of hydrotropic nicotinamide with nanoparticles for enhancing tacrolimus percutaneous deliveryInt J Nanomedicine2016114037405027578973
   PubMed Web of Science ®Google Scholar
• WanTPanJLongYDual roles of TPGS based microemulsion for tacrolimus: enhancing the percutaneous delivery and anti-psoriatic efficacyInt J Pharm20175281–251152328629978
   PubMed Web of Science ®Google Scholar
• LeeSGKangJBKimSREnhanced topical delivery of tacrolimus by a carbomer hydrogel formulation with transcutol PDrug Dev Ind Pharm201642101636164226925849
   PubMed Web of Science ®Google Scholar
• GoebelASNeubertRHWohlrabJDermal targeting of tacrolimus using colloidal carrier systemsInt J Pharm20114041–215916821094231
   PubMedGoogle Scholar
• SavićVTodosijevićMIlićTTacrolimus loaded biocompatible lecithin-based microemulsions with improved skin penetration: structure characterization and in vitro/in vivo performancesInt J Pharm20175291–249150528711641
   PubMedGoogle Scholar
• LiGFanYFanCTacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluationEur J Pharm Biopharm2012821495722705640
   PubMed Web of Science ®Google Scholar
• PoplePVSinghKKTargeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitisInt J Pharm20103981–216517820637847
   PubMedGoogle Scholar
• AndradeLMSilvaLADKrawczyk-SantosAPImproved tacrolimus skin permeation by co-encapsulation with clobetasol in lipid nanoparticles: study of drug effects in lipid matrix by electron paramagnetic resonanceEur J Pharm Biopharm201711914214928627400
   PubMed Web of Science ®Google Scholar
• PoplePVSinghKKDevelopment and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimusEur J Pharm Biopharm2011791829421447390
   PubMed Web of Science ®Google Scholar
• LaptevaMMondonKMöllerMGurnyRKaliaYNPolymer micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasisMol Pharm20141192989300125057896
   PubMed Web of Science ®Google Scholar
• MathesCMeleroAConradPNanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effectsJ Control Release201622320721426686081
   PubMed Web of Science ®Google Scholar
• SilvaCORijoPMolpeceresJPolymeric nanoparticles modified with fatty acids encapsulating betamethasone for anti-inflammatory treatmentInt J Pharm20154931–227128426222745
   PubMed Web of Science ®Google Scholar
• SamadMBChhonkerYSContrerasJDeveloping polyamine-based peptide amphiphiles with tunable morphology and physicochemical propertiesMacromol Biosci2017178
   PubMed Web of Science ®Google Scholar
• HuBYuanYYanYPreparation and evaluation of a novel anticancer drug delivery carrier for 5-fluorouracil using synthetic bolaamphiphile based on lysine as polar headsMater Sci Eng C Mater Biol Appl20177563764528415509
   PubMed Web of Science ®Google Scholar
• RaafatDSahlHGChitosan and its antimicrobial potential – a critical literature surveyMicrob Biotechnol20092218620121261913
   PubMed Web of Science ®Google Scholar
• ZhangZTsaiPCRamezanliTMichniak–KohnBBPloymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseasesWiley Interdiscip Rev Nanomed Nanobiotechnol20135320521823386536
   PubMed Web of Science ®Google Scholar
• Al-KassasRWenJChengAEKimAMLiuSSMYuJTransdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gelCarbohydr Polym201615317618627561485
   PubMed Web of Science ®Google Scholar
• JeJYKimSKChitosan derivatives killed bacteria by disrupting the outer and inner membraneJ Agric Food Chem200654186629663316939319
   PubMed Web of Science ®Google Scholar
• HussainZKatasHAminMCKumulosasiESahudinSAntidermatitic perspective of hydrocortisone as chitosan nanocarriers: an ex vivo and in vivo assessment using an NC/Nga mouse modelJ Pharm Sci201310231063107523303620
   PubMed Web of Science ®Google Scholar
• KhalilSKEl-FekyGSEl-BannaSTKhalilWAPreparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal deliveryCarbohydr Polym20129031244125322939337
   PubMed Web of Science ®Google Scholar
• RasoolAAHussainAADittertLWSolubility enhancement of some water-insoluble drugs in the presence of nicotinamide and related compoundsJ Pharm Sci19918043873931830901
   PubMed Web of Science ®Google Scholar
• LimLYGoMLCaffeine and nicotinamide enhances the aqueous solubility of the antimalarial agent halofantrineEur J Pharm Sci2000101172810699380
   PubMed Web of Science ®Google Scholar
• FanXChenJShenQDocetaxel–nicotinamide complex-loaded nanostructured lipid carriers for transdermal deliveryInt J Pharm2013458229630424177313
   PubMed Web of Science ®Google Scholar
• HuangYZhangBGaoYZhangJShiLBaicalein–nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailabilityJ Pharm Sci201410382330233724903146
   PubMed Web of Science ®Google Scholar
• WohlrabJKreftDNiacinamide – mechanisms of action and its topical use in dermatologySkin Pharmacol Physiol201427631131524993939
   PubMed Web of Science ®Google Scholar
• UngerstedtJSBlömbackMSöderströmTNicotinamide is a potent inhibitor of proinflammatory cytokinesClin Exp Immunol20031311485212519385
   PubMed Web of Science ®Google Scholar
• RampinoABorgognaMBlasiPBellichBCesàroAChitosan nanoparticles: preparation, size evolution and stabilityInt J Pharm20134551–221922823886649
   PubMed Web of Science ®Google Scholar
• GanQWangTCochraneCMcCarronPModulation of surface charge, particle size and morphological properties of chitosan–TPP nanoparticles intended for gene deliveryColloids Surf B Biointerfaces2005442–3657316024239
   PubMed Web of Science ®Google Scholar
• LimSKKwonMSLeeJWeissella cibaria WIKIM28 ameliorates atopic dermatitis-like skin lesions by inducing tolerogenic dendritic cells and regulatory T cells in BALB/c miceSci Rep201774004028067304
   PubMed Web of Science ®Google Scholar
• LeungDYHirschRLSchneiderLThymopentin therapy reduces the clinical severity of atopic dermatitisJ Allergy Clin Immunol19908559279332185294
   PubMed Web of Science ®Google Scholar
• HashimotoYTakaokaASugimotoMItch-associated scratching contributes to the development of dermatitis and hyperimmunoglobulinaemia E in NC/Nga miceExp Dermatol2011201082082521771100
   PubMed Web of Science ®Google Scholar
• Abdel-MottalebMMMoulariBBeduneauAPellequerYLamprechtANanoparticles enhance therapeutic outcome in inflamed skin therapyEur J Pharm Biopharm201282115115722728016
   PubMed Web of Science ®Google Scholar
• Alvarez-RománRNaikAKaliaYNGuyRHFessiHSkin penetration and distribution of polymeric nanoparticlesJ Control Release2004991536215342180
   PubMed Web of Science ®Google Scholar
• JenningVGyslerASchäfer-KortingMGohlaSHVitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skinEur J Pharm Biopharm200049321121810799811
   PubMed Web of Science ®Google Scholar
• VogtAWischkeCNeffeATMaNAlexievULendleinANanocarriers for drug delivery into and through the skin – do existing technologies match clinical challenges?J Control Release201624231527449743
   PubMed Web of Science ®Google Scholar
• ProwTWGriceJELinLLNanoparticles and microparticles for skin drug deliveryAdv Drug Deliv Rev201163647049121315122
   PubMed Web of Science ®Google Scholar
• SomaYKashimaMImaizumiATakahamaHKawakamiTMizoguchiMMoisturizing effects of topical nicotinamide on atopic dry skinInt J Dermatol200544319720215807725
   PubMed Web of Science ®Google Scholar
• Escudero-GóngoraMMFernández-PeñasPNicotinamide: new indications in dermatologyActas Dermosifiliogr2016107977777827377936
   PubMedGoogle Scholar
• NamaziMRNicotinamide in dermatology: a capsule summaryInt J Dermatol200746121229123118173513
   PubMed Web of Science ®Google Scholar
• ChenACMartinAJChoyBA phase 3 randomized trial of nicotinamide for skin-cancer chemopreventionN Engl J Med2015373171618162626488693
   PubMed Web of Science ®Google Scholar
• MohammedDCrowtherJMMattsPJHadgraftJLaneMEInfluence of niacinamide containing formulations on the molecular and biophysical properties of the stratum corneumInt J Pharm20134411–219220123220080
   PubMedGoogle Scholar
• OffertaABoninaFGasparriFZanardiAMiciccheLPugliaCIn vitro percutaneous absorption of niacinamide and phytosterols and in vivo evaluation of their effect on skin barrier recoveryCurr Drug Deliv201613111112026201345
   PubMed Web of Science ®Google Scholar
• ChenACDamianDLNicotinamide and the skinAustralas J Dermatol201455316917524635573
   PubMed Web of Science ®Google Scholar
• ChanCCLiouCJXuPYEffect of dehydroepiandrosterone on atopic dermatitis-like skin lesions induced by 1–chloro–2,4–dinitrobenzene in mouseJ Dermatol Sci201372214915723891346
   PubMed Web of Science ®Google Scholar
• KangBKKimMJKimKBAhnDHIn vivo and in vitro inhibitory activity of an ethanolic extract of Sargassum fulvellum and its component grasshopper ketone on atopic dermatitisInt Immunopharmacol20164017618327608302
   PubMed Web of Science ®Google Scholar
• TannoOOtaYKitamuraNKatsubeTInoueSNicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrierBr J Dermatol2000143352453110971324
   PubMed Web of Science ®Google Scholar
• GreensteinRJSuLBrownSTGrowth of M. avium subspecies paratuberculosis in culture is enhanced by nicotinic acid, nicotinamide, and α and β nicotinamide adenine dinucleotideDig Dis Sci201156236837520585983
   PubMed Web of Science ®Google Scholar
• MoëllASkogOAhlinEKorsgrenOFriskGAntiviral effect of nicotinamide on enterovirus-infected human islets in vitro: effect on virus replication and chemokine secretionJ Med Virol20098161082108719382275
   PubMed Web of Science ®Google Scholar
• QiLXuZJiangXHuCZouXPreparation and antibacterial activity of chitosan nanoparticlesCarbohydr Res200433991626932700
   Google Scholar